Content uploaded by Shahin Aghaei
Author content
All content in this area was uploaded by Shahin Aghaei on Jun 23, 2021
Content may be subject to copyright.
Available via license: CC BY-NC 4.0
Content may be subject to copyright.
doi: 10.18282/jsd.v1.i2.67
Copyright © 2016 Aghaei S. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0
International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.
55
EDITORIAL
An approach to dark circles under the eyes
Shahin Aghaei
Iran University of Medical Sciences, Tehran, Islamic Republic of Iran
Keywords: Infraorbital darkening, periorbital darkening, dark circles, eyes, treatment, therapy
Citation: Aghaei S. An approach to dark circles under the eyes. J Surg Dermatol 2016; 1(2): 55–56;
http://dx.doi.org/10.18282/jsd.v1.i2.67.
Correspondence to: Shahin Aghaei, Roonik Skin Clinic, #78, Asad-abadi Ave., Tehran, Islamic Republic of Iran,
shahinaghaei@yahoo.com
Received: 12th July 2016; Published Online: 29th July 2016
ho does not loath looking in the mirror after
a long and sleepless night? Periorbital
melanosis, popularly known as “dark circles”
(DC) under the eyes, is a common and frustrating
cosmetic grievance in both men and women, although in
most cases it is not a sign of a severe medical
condition[1,2]. DC is inevitably a sign of exhaustion, but
anxiety seems to deteriorate facial appearance through
the development of DC[3].
There has been little research dedicated to
investigating the cause of this common disorder. The fact
that various treatment modalities carried out in the past
resulted in inconsistent outcomes shows that pinpointing
the cause of DC is not exactly a walk in the park. There
are multiple factors that cause DC in a majority of
patients. Possible reasons include excessive pigmentation,
along with thin and luminous lower eyelid skin overlying
the orbicularis oculi muscle. As people grow older, the
skin gets thinner and collagen fibers are lost, at times
augmenting the advent of tiny blood vessels beneath the
eyes, thus making the area seems darker. While lack of
sleep and aging certainly play a role in under-eye
discoloration, so do genetics, allergies, hormonal
abnormalities, and accumulated skin damage[4,5].
Certain conditions such as fluid disproportion or
locally swollen eyelids can also cause shades that make
the area under the eyes seem darker. Some researchers
also speculated that DC has a tendency to run in families.
Brown circles could also form as a result of hyperpig-
mentation triggered by chronic eye-rubbing, sun
exposure, or genetics. When there is no apparent cause, it
could be due to termed idiopathic cutaneous
hyperchromia of the orbital region (ICHOR)[6].
Numerous treatments have been used for this complaint
with various results, including topical lightening creams,
chemical peelings, lasers, and even fat injections. None
of the treatments have proven to be uniformly effective
and thus there is a need for newer approaches[7-9].
In spite of its prevalence and cosmetic importance,
there are only a few reported works in literature
regarding DC. A virtuous description of this condition is
unavailable and there is neither an overall understanding
about the pathogenesis nor an agreement about the main
factors responsible for it. Treatment modalities are
chosen in empirical ways, frequently resulting in
suboptimal outcomes. It is important to identify the
probable cause and choose appropriate treatment
methods.
DC is less responsive to standard treatments due to
its multifactorial etiology and the presence of melanin in
skin layers. Nevertheless, even a mild-to-moderate
improvement in appearance can enhance the quality of
life of patients; hence topical therapies and simple
physical therapies can be used to treat patients seeking to
improve the cosmetic appearance of their eyes[10]. Instead
of fighting an uphill battle against the genes, one can also
turn to corrective coloring makeup.
W
Aghaei S
56
doi: 10.18282/jsd.v1.i2.67
Conflict of interest
The author declared no potential conflict of interest with
respect to the research, authorship, and/or publication of
this article.
References
1. West TB, Alister TS. Improvement of infraorbital
hyperpigmentation following carbon dioxide laser
resurfacing. Dermatol Surg 1998; 24(6): 615–616. doi:
10.1111/j.1524-4725.1998.tb04216.x.
2. Sheth PB, Shah HA, Dave JN. Periorbital
hyperpigmentation: A study of its prevalence, common
causative factors and its association with personal habits
and other disorders. Indian J Dermatol 2014; 59(2): 151–
157. doi: 10.4103/0019-5154.127675.
3. Roberts WE. Periorbital hyperpigmentation: Review of
etiology, medical evaluation, and aesthetic treatment. J
Drugs Dermatol 2014; 13(4): 472–482.
4. Freitag FM, Cestari TF. What causes dark circles under the
eyes? J Cosmet Dermatol 2007; 6(3): 211–215. doi:
10.1111/j.1473-2165.2007.00324.x.
5. Verschoore M, Gupta S, Sharma VK, Ortonne JP.
Determination of melanin and haemoglobin in the skin of
idiopathic cutaneous hyperchromia of the orbital region
(ICHOR): A study of Indian patients. J Cutan Aesthet Surg
2012; 5(3): 176–182. doi: 10.4103/0974-2077.101371.
6. Huang YL, Chang SL, Ma L, Lee MC, Hu S. Clinical
analysis and classification of dark eye circle. Int J
Dermatol 2014; 53(2): 164–170. doi: 10.1111/j.1365-
4632.2012.05701.x.
7. Kontochristopoulos G, Kouris A, Platsidaki E, Markantoni
V, Gerodimou M, et al. Combination of microneedling and
10% trichloroacetic acid peels in the management of
infraorbital dark circles. J Cosmet Laser Ther 2016;
18(5):289–292. doi: 10.3109/14764172.2016.1157363.
8. Sahni K, Kassir M. Dermafrac™: An innovative new
treatment for periorbital melanosis in a dark-skinned male
patient. J Cutan Aesthet Surg 2013; 6(3): 158–160. doi:
10.4103/0974-2077.118420.
9. Hassan AM, Hassan GFR, Aldalies HY, El Maghraby GM.
Treatment of periorbital dark circles: Comparative study of
chemical peeling with a combination of trichloroacetic acid
and lactic acid versus carboxytherapy. J Surg Dermatol
2016; 1(2): 108–115. doi: 10.18282/jsd.v1.i2.29.
10. Sarkar R, Ranjan R, Garg S, Garg VK, Sonthalia S et al.
Periorbital hyperpigmentation: A comprehensive review. J
Clin Aesthet Dermatol 2016; 9(1): 49–55.